Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events

Funding Opportunity Number: CDC-RFA-CK16-004 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.084Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Jan 15, 2016Award Ceiling: $500,000Expected Number of Awards: 5Creation Date: Oct 30, 2015Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to support the translation of basic, epidemiologic and technologic discoveries into new strategies for preventing and decreasing the incidence of healthcare-associated infections (HAIs), antimicrobial resistance (AR) and other adverse events in all types of healthcare facilities in the United States. CDC is interested in building upon research gains accomplished under FOA CK11-001: Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events over the past 5 years

Source: Grants.gov - October 31, 2015 Category: Research Tags: Health Source Type: funding